Kirsten Hopkins

Suggest Changes
Learn More
SirdUntil 2004, treatment for patientswith glioblastoma multiforme comprised surgical debulking followed by radiotherapy. Themost important advance in recent yearshas been the addition of concomitant(More)
Purpose Bevacizumab regimens are approved for the treatment of recurrent glioblastoma in many countries. Aberrant mesenchymal-epithelial transition factor (MET) expression has been reported in(More)
PURPOSE To determine the impact on overall survival with different salvage therapies, including no treatment, reirradiation, systemic therapy, or radiation and systemic therapy, in participants of a(More)